Suppr超能文献

日本实施水痘普遍两剂次接种4年后水痘患者的趋势。

Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan.

作者信息

Hattori Fumihiko, Kozawa Kei, Miura Hiroki, Kawamura Yoshiki, Higashimoto Yuki, Yoshikawa Akiko, Ihira Masaru, Yoshikawa Tetsushi

机构信息

Department of Pediatrics, Kariya Toyota General Hospital, Kariya, Aichi 448-8505, Japan; Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

出版信息

Vaccine. 2020 Oct 27;38(46):7331-7336. doi: 10.1016/j.vaccine.2020.09.038. Epub 2020 Sep 30.

Abstract

OBJECTIVE

To elucidate the trend and clinical spectrum of virologically diagnosed varicella patients after implementation of universal vaccination as a national immunization program in Japan.

PATIENTS AND METHODS

Study subjects were patients suspected of varicella, less than 15 years of age, who visited 14 pediatric clinics in the Nagoya VZV Study Group from September 2015 to August 2019. Practitioners collected patient samples and information such as backgrounds, clinical symptoms, and previous immunization status. All patients were confirmed as having varicella based on molecular diagnostic assays.

RESULTS

Varicella zoster virus (VZV) DNA was detected in swab samples from 506 (83.1%) of the 609 suspected patients. The 455 varicella patients for whom vaccination status was available were divided into two groups: 180 universal vaccination targets and 275 non-targets. Numbers of monthly varicella patients decreased gradually during the observation period. In the 2016/17 season, the seasonal epidemic of varicella became undetectable in the universal vaccination target group, and starting in the 2017/18 season, it was obscured even in the non-target group. The median age of patients was significantly lower in the universal vaccination target group (3 years) than the non-target group (7 years) (P < 0.001). Vaccination status differed significantly between the two groups (P < 0.001). Most varicella patients were in the non-target group, especially those who had been vaccinated once (60.4%). Frequency of fever (P < 0.001) and number of skin rashes at the time of the first hospital visit (P = 0.001) were significantly higher in the non-target group.

CONCLUSIONS

Although the number of childhood varicella patients declined after implementation of national immunization with two doses of varicella vaccination, sporadic outbreaks still occurred, mainly in the non-universal vaccination target group. Insufficient vaccination of members of this group is likely to be a major reason for small local outbreaks.

摘要

目的

阐明日本将水痘疫苗普遍接种作为国家免疫规划实施后,病毒学确诊的水痘患者的发病趋势和临床特征。

患者与方法

研究对象为2015年9月至2019年8月期间,前往名古屋水痘带状疱疹病毒(VZV)研究组下属14家儿科诊所就诊的疑似水痘患者,年龄小于15岁。医生收集了患者样本以及背景、临床症状和既往免疫状况等信息。所有患者均通过分子诊断检测确诊为水痘。

结果

609名疑似患者中,506名(83.1%)的拭子样本检测到水痘带状疱疹病毒(VZV)DNA。455名有疫苗接种情况的水痘患者分为两组:180名普遍接种疫苗对象和275名非普遍接种疫苗对象。观察期间,每月水痘患者数量逐渐减少。在2016/17季节,普遍接种疫苗对象组中水痘季节性流行已无法察觉,从2017/18季节开始,非普遍接种疫苗对象组中也不明显了。普遍接种疫苗对象组患者的中位年龄(3岁)显著低于非普遍接种疫苗对象组(7岁)(P<0.001)。两组的疫苗接种情况差异显著(P<0.001)。大多数水痘患者属于非普遍接种疫苗对象组,尤其是接种过一剂疫苗的患者(60.4%)。非普遍接种疫苗对象组发热频率(P<0.001)和首次就诊时皮疹数量(P=0.001)显著更高。

结论

尽管实施两剂水痘疫苗国家免疫后儿童水痘患者数量有所下降,但仍有散发病例,主要发生在非普遍接种疫苗对象组。该组人群疫苗接种不足可能是局部小规模暴发的主要原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验